CLDI Q4 2025 Earnings Smallerthanexpected loss highlights progress in clinicalstage biotherapeutics CRESY Q1 2026 Earnings Robust EPS Driven by Operational Strength and Favorable Currency Adjustments American Realty Investors ARL Q3 2024 Earnings Widening Loss Amid No Consensus Estimate SLGL Q4 2025 Earnings EPS Misses Estimates as DevelopmentStage Biotech Reports No Revenue BNTX Q1 2026 Earnings NarrowerThanExpected Loss as BioNTech Focuses on Pipeline Progress WGRX Q1 2026 Earnings Negative EPS and No Revenue Reported Stock Plunges 22